These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 28094771)
1. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. Kechele DO; Blue RE; Zwarycz B; Espenschied ST; Mah AT; Siegel MB; Perou CM; Ding S; Magness ST; Lund PK; Caron KM J Clin Invest; 2017 Feb; 127(2):593-607. PubMed ID: 28094771 [TBL] [Abstract][Full Text] [Related]
2. Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response. Jayakumar A; Bothwell ALM Neoplasia; 2017 Aug; 19(8):595-605. PubMed ID: 28654863 [TBL] [Abstract][Full Text] [Related]
3. Epimorphin deletion inhibits polyposis in the Apcmin/+ mouse model of colon carcinogenesis via decreased myofibroblast HGF secretion. Swietlicki EA; Bala S; Lu J; Shaker A; Kularatna G; Levin MS; Rubin DC Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G564-72. PubMed ID: 23886856 [TBL] [Abstract][Full Text] [Related]
4. GPR182 is a novel marker for sinusoidal endothelial differentiation with distinct GPCR signaling activity in vitro. Schmid CD; Schledzewski K; Mogler C; Waldburger N; Kalna V; Marx A; Randi AM; Géraud C; Goerdt S; Koch PS Biochem Biophys Res Commun; 2018 Feb; 497(1):32-38. PubMed ID: 29408502 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079 [TBL] [Abstract][Full Text] [Related]
6. GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis. Le Mercier A; Bonnavion R; Yu W; Alnouri MW; Ramas S; Zhang Y; Jäger Y; Roquid KA; Jeong HW; Sivaraj KK; Cho H; Chen X; Strilic B; Sijmonsma T; Adams R; Schroeder T; Rieger MA; Offermanns S Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33875597 [TBL] [Abstract][Full Text] [Related]
7. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Zhang T; Nanney LB; Luongo C; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD Cancer Res; 1997 Jan; 57(1):169-75. PubMed ID: 8988060 [TBL] [Abstract][Full Text] [Related]
8. The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling. Kwon HB; Mackie DI; Bonnavion R; Mercier AL; Helker CSM; Son T; Guenter S; Serafin DS; Kim KW; Offermanns S; Caron KM; Stainier DYR ACS Pharmacol Transl Sci; 2020 Aug; 3(4):676-689. PubMed ID: 32832870 [TBL] [Abstract][Full Text] [Related]
9. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Arimura S; Matsunaga A; Kitamura T; Aoki K; Aoki M; Taketo MM Gastroenterology; 2009 Aug; 137(2):629-38. PubMed ID: 19427313 [TBL] [Abstract][Full Text] [Related]
10. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720 [TBL] [Abstract][Full Text] [Related]
11. Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice. Bashir O; Fitzgerald AJ; Berlanga-Acosta J; Playford RJ; Goodlad RA Clin Sci (Lond); 2003 Sep; 105(3):323-30. PubMed ID: 12749762 [TBL] [Abstract][Full Text] [Related]
12. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice. Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863 [TBL] [Abstract][Full Text] [Related]
13. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Powell AE; Wang Y; Li Y; Poulin EJ; Means AL; Washington MK; Higginbotham JN; Juchheim A; Prasad N; Levy SE; Guo Y; Shyr Y; Aronow BJ; Haigis KM; Franklin JL; Coffey RJ Cell; 2012 Mar; 149(1):146-58. PubMed ID: 22464327 [TBL] [Abstract][Full Text] [Related]
14. Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells. Yao R; Oyanagi J; Natsume Y; Kusama D; Kato Y; Nagayama S; Noda T Oncogene; 2016 Nov; 35(47):6109-6119. PubMed ID: 27157623 [TBL] [Abstract][Full Text] [Related]
16. Betacellulin stimulates growth of the mouse intestinal epithelium and increases adenoma multiplicity in Apc+/Min mice. Dahlhoff M; Horst D; Gerhard M; Kolligs FT; Wolf E; Schneider MR FEBS Lett; 2008 Aug; 582(19):2911-5. PubMed ID: 18656477 [TBL] [Abstract][Full Text] [Related]
18. APC in the regulation of intestinal crypt fission. Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477 [TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636 [TBL] [Abstract][Full Text] [Related]
20. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]